-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q2 2024.
- Eton Pharmaceuticals, Inc. Depreciation for the quarter ending June 30, 2024 was $12K, a 20% increase year-over-year.
- Eton Pharmaceuticals, Inc. Depreciation for the twelve months ending June 30, 2024 was $47K, a 6% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Depreciation for 2023 was $44K, a 33.3% decline from 2022.
- Eton Pharmaceuticals, Inc. annual Depreciation for 2022 was $66K, a 57.4% decline from 2021.
- Eton Pharmaceuticals, Inc. annual Depreciation for 2021 was $155K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)